SCHEMBL381817

SCHEMBL381817

CC(C)(C)N(C(=O)O)C(CS(C)(=O)=O)c1ccccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.39
NISCH Q9Y2I1 1/20 0.39
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
CYP2D6 P10635 1/20 0.37
NFKB1 P19838 1/20 0.37
HIF1A Q16665 1/20 0.37
BLM P54132 1/20 0.36
AOC3 Q16853 1/20 0.35
HTT P42858 1/20 0.34
FDFT1 P37268 1/20 0.34
CXCL8 P10145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19244867 0.84 OPRM1 (0.42) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL382379 0.83 NISCH (0.43) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL381471 0.82 NISCH (0.56) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL19244870 0.82 CNR2 (0.40)
SCHEMBL19244837 0.81 NISCH (0.41) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL19244883 0.80 OPRM1 (0.41) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL409383 0.78 OPRM1 (0.39) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL382108 0.78 ALDH1A1 (0.41) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL19244810 0.77 OPRM1 (0.48) OPRM1NISCHADRB2ADRB1CYP2D6
SCHEMBL19244871 0.75 MMP1 (0.37) ADRB2ADRB1CYP2D6NFKB1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed